Our commitment to the field of infectious diseases is an active one. We're expanding
the knowledge base of this therapeutic area and empowering physicians to make evidence
- based clinical decisions.
Our proud history of collaborating with investigators around the world provides
ideal environments to study compounds that have the potential for significant breakthroughs
and allows us to generate and publish key information on our advances. In fact,
Astellas pioneered the empiric antifungal clinical trial and has performed some
of the world's largest clinical trials in fungal infections.
This information is intended for U.S. residents only.